11/06/2024 3:05 PM | Merck & Co., Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 3:09 PM | Evaxion Biotech A/S (Subject) Merck & Co., Inc. (Filed by)
| Form SC 13G/A | |
11/04/2024 9:05 AM | Merck & Co., Inc. (Subject) NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
10/31/2024 5:44 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2024 1:06 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 1:10 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 1:16 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/06/2024 11:20 AM | Guindo Chirfi (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 5:41 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 12:20 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 12:23 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 12:25 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 12:37 PM | Merck & Co., Inc. (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024 12:37 PM | Merck & Co., Inc. (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024 12:38 PM | Merck & Co., Inc. (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/04/2024 1:55 PM | Merck & Co., Inc. (Issuer) Rothman Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:59 PM | Merck & Co., Inc. (Issuer) Warden Kathy J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 2:00 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 2:02 PM | Merck & Co., Inc. (Issuer) RUSSO PATRICIA F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:41 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:44 PM | BAKER DOUGLAS M JR (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:44 PM | Merck & Co., Inc. (Issuer) THULIN INGE G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:32 PM | Mayo Stephen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:34 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:38 PM | Craig Pamela J. (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 1:15 PM | LAVIZZO-MOUREY RISA J (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:39 PM | Merck & Co., Inc. (Filer)
| Form CERT | |
05/20/2024 5:28 AM | Merck & Co., Inc. (Filer) MSD Netherlands Capital B.V. (Filer)
| Form 424B5 | |
05/15/2024 10:31 AM | Merck & Co., Inc. (Filer) MSD Netherlands Capital B.V. (Filer)
| Form POSASR | |
05/06/2024 3:29 PM | Merck & Co., Inc. (Subject) MIZELL STEVEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 3:15 PM | Merck & Co., Inc. (Issuer) Oosthuizen Johannes Jacobus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:17 PM | Li Dean Y (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:19 PM | Merck & Co., Inc. (Issuer) Zachary Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 5:41 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 3:05 PM | Merck & Co., Inc. (Filer)
| Form 10-K/A | |
04/11/2024 3:08 PM | Merck & Co., Inc. (Filer)
| Form DEF 14A | |
04/11/2024 3:10 PM | Merck & Co., Inc. (Filer)
| Form DEFA14A | |
04/11/2024 3:12 PM | Merck & Co., Inc. (Filer)
| Form ARS | |
04/08/2024 12:56 PM | Larson Betty D (Reporting) Merck & Co., Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/01/2024 4:16 PM | Inspire Investing, LLC (Filed by) Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/29/2024 3:12 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Donald Trump can’t save you from this crisis (Ad) Elon Musk: “This Is The Most Destructive Force In History”
Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about? Get the full details now. |
03/29/2024 3:14 PM | GLOCER THOMAS H (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 3:16 PM | Merck & Co., Inc. (Issuer) Seidman Christine E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 3:18 PM | Merck & Co., Inc. (Issuer) WENDELL PETER C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:57 PM | Bowyer Research, Inc. (Filed by) Merck & Co., Inc. (Subject)
| Form PX14A6G | |
03/11/2024 2:27 PM | Harpoon Therapeutics, Inc. (Issuer) Merck & Co., Inc. (Reporting) MERCK SHARP & DOHME LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:24 PM | Davis Robert M (Reporting) Merck & Co., Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024 3:01 PM | Merck & Co., Inc. (Issuer) Oosthuizen Johannes Jacobus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:35 PM | Merck & Co., Inc. (Subject) Oosthuizen Johannes Jacobus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 5:39 AM | Merck & Co., Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 2:29 PM | Evaxion Biotech A/S (Subject) Merck & Co., Inc. (Filed by)
| Form SC 13G | |
01/17/2024 4:52 PM | Harpoon Therapeutics, Inc. (Issuer) Merck & Co., Inc. (Reporting) MERCK SHARP & DOHME LLC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 3:27 PM | Merck & Co., Inc. (Issuer) WENDELL PETER C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:18 PM | Coe Mary Ellen (Reporting) Merck & Co., Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 4:27 PM | Merck & Co., Inc. (Issuer) Smart Dalton (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |